Loading...
XSHG
600645
Market cap1.85bUSD
Dec 05, Last price  
28.76CNY
1D
-0.07%
1Q
13.90%
Name

Zhongyuan Union Cell & Gene Eng Corp Ltd

Chart & Performance

D1W1MN
XSHG:600645 chart
P/E
130.65
P/S
8.27
EPS
0.22
Div Yield, %
Shrs. gr., 5y
0.19%
Rev. gr., 5y
2.71%
Revenues
1.59b
-0.27%
354,367,347407,355,448392,188,205288,105,421307,749,244268,473,344246,737,638300,342,739361,309,762476,864,594708,994,855837,900,550870,913,4971,320,517,6771,386,778,8481,318,893,8561,535,328,6531,554,886,9431,589,723,3331,585,423,174
Net income
100m
-5.73%
07,975,62511,875,29739,097,7702,124,8718,380,45123,426,18813,898,9007,215,73335,464,991208,353,11337,859,920059,252,90449,694,8010155,320,080112,986,649106,452,669100,352,111
CFO
285m
-4.62%
84,686,47976,115,125111,679,834121,602,969124,917,732175,925,959110,444,59370,409,955110,722,693221,454,6968,174,936143,667,30870,269,191130,081,956241,490,023244,354,437320,957,061261,890,840299,015,343285,187,932
Dividend
Aug 10, 20010.016 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental synthetic agents; and in vitro diagnostic reagents and medical devices. Vcanbio Cell & Gene Engineering Corp., Ltd was founded in 1992 and is based in Tianjin, the People's Republic of China.
IPO date
May 04, 1993
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT